DK-MCD Career Symposium 2021

Corina Madreiter-Sokolowski started her scientific career with a Master’s degree in Pharmacy at the University of Graz. After that, she joined the Ph.D. Program Metabolic and Cardiovascular Disease of the Medical University of Graz, investigating mitochondrial Ca²⁺ homeostasis in cancer and aging-related processes. After she finished her Ph.D. studies with distinction in 2016, she started to work as a University Assistant at Gottfried Schatz Research Center. In 2018, she worked in the Regulatory Affairs Department at Gerot Lannach Pharma, before starting her FWF-funded Schrödinger project at the Department of Health Sciences and Technology, ETH Zurich. In 2020, she was appointed as assistant professor (tenure track) to the Molecular Biology and Biochemistry of the Gottfried Schatz Research Center, Medical University of Graz. Her research team investigates the age-associated alterations using various in vitro aging models and Caenorhabditis elegans.

Anna Obenauf began her scientific career with a bachelor's degree in molecular biology, followed by a master's degree, both at Karl Franzens University Graz. She performed her doctoral studies at the Medical University of Graz with Michael Speicher, graduating with honors in 2010 and receiving the Austrian "Award of Excellence" for her dissertation. She then worked as a postdoctoral fellow with Joan Massagué at Memorial Sloan Kettering Cancer Center (MSKCC) in New York until 2015. Her work "Therapy induced tumor secretomes promote resistance and tumor progression" was awarded the ASCINA prize by the Federal Department of Education. Since 2016, she has been working as a junior group leader at the Research Institute of Molecular Pathology at the Vienna BioCenter, investigating novel therapeutic approaches and rational therapeutic combinations for metastatic cancers. Her work is funded by prestigious grants, such as an ERC starting grant and she was elected as a member of the Young Academy of the Austrian Academy of Sciences in 2019 and the EMBO Young Investigator Programme in 2021. She was recently promoted to Senior Group Leader at the Research Institute of Molecular Pathology in Vienna.

Vinay Sachdev, PhD, is currently a postdoctoral fellow in the Department of Medical Biochemistry at the University of Amsterdam. He has dedicated a good part of the last decade to cracking the molecular intricacies of lipid dysregulation in various human disease models. His current research is focused on characterization of a novel post-translational protein modification of proteins in NAFLD progression. More precisely, he is investigating the role of a recently identified ER-resident E3 ubiquitin ligase MARCH6 as a potential regulator of key mediators in lipid biosynthesis in murine and human models.
Vinay Sachdev has a background in pharmacy (B. Pharmacy, India) and molecular biology (Msc., Sweden). He completed his doctorate in 2017 at the Medical University of Graz under supervision of Prof. Dagmar Kratky.

Rainer Schindl started his scientific career with a bachelor’s degree in Biophysics at Johannes Kepler University Linz. Thereafter, he started a PhD in technical sciences, investigating Ca signaling and gene regulation. In 2016, Rainer completed his habilitation in biophysics at Johannes Kepler University Linz and then he started as a Principal investigator at Medical University Graz. He is active in several interdisciplinary projects combining single cell signalling with computer science, structural biology, material science and neuro-science. His last research project, ‘ELPHI: A Next Generation Device for Brain Cancer Treatment’, was selected 1000 Ideas Project Program. In 2021, he was promoted as Assoc. Professor for Electrophysiology and Bioelectronic medicine at Medical University of Graz.

	Corina Madreiter-Sokolowski started her scientific career with a Master’s degree in Pharmacy at the University of Graz. After that, she joined the Ph.D. Program Metabolic and Cardiovascular Disease of the Medical University of Graz, investigating mitochondrial Ca²⁺ homeostasis in cancer and aging-related processes. After she finished her Ph.D. studies with distinction in 2016, she started to work as a University Assistant at Gottfried Schatz Research Center. In 2018, she worked in the Regulatory Affairs Department at Gerot Lannach Pharma, before starting her FWF-funded Schrödinger project at the Department of Health Sciences and Technology, ETH Zurich. In 2020, she was appointed as assistant professor (tenure track) to the Molecular Biology and Biochemistry of the Gottfried Schatz Research Center, Medical University of Graz. Her research team investigates the age-associated alterations using various in vitro aging models and Caenorhabditis elegans.
Anna Obenauf began her scientific career with a bachelor's degree in molecular biology, followed by a master's degree, both at Karl Franzens University Graz. She performed her doctoral studies at the Medical University of Graz with Michael Speicher, graduating with honors in 2010 and receiving the Austrian "Award of Excellence" for her dissertation. She then worked as a postdoctoral fellow with Joan Massagué at Memorial Sloan Kettering Cancer Center (MSKCC) in New York until 2015. Her work "Therapy induced tumor secretomes promote resistance and tumor progression" was awarded the ASCINA prize by the Federal Department of Education. Since 2016, she has been working as a junior group leader at the Research Institute of Molecular Pathology at the Vienna BioCenter, investigating novel therapeutic approaches and rational therapeutic combinations for metastatic cancers. Her work is funded by prestigious grants, such as an ERC starting grant and she was elected as a member of the Young Academy of the Austrian Academy of Sciences in 2019 and the EMBO Young Investigator Programme in 2021. She was recently promoted to Senior Group Leader at the Research Institute of Molecular Pathology in Vienna.
	Vinay Sachdev, PhD, is currently a postdoctoral fellow in the Department of Medical Biochemistry at the University of Amsterdam. He has dedicated a good part of the last decade to cracking the molecular intricacies of lipid dysregulation in various human disease models. His current research is focused on characterization of a novel post-translational protein modification of proteins in NAFLD progression. More precisely, he is investigating the role of a recently identified ER-resident E3 ubiquitin ligase MARCH6 as a potential regulator of key mediators in lipid biosynthesis in murine and human models. Vinay Sachdev has a background in pharmacy (B. Pharmacy, India) and molecular biology (Msc., Sweden). He completed his doctorate in 2017 at the Medical University of Graz under supervision of Prof. Dagmar Kratky.	Rainer Schindl started his scientific career with a bachelor’s degree in Biophysics at Johannes Kepler University Linz. Thereafter, he started a PhD in technical sciences, investigating Ca signaling and gene regulation. In 2016, Rainer completed his habilitation in biophysics at Johannes Kepler University Linz and then he started as a Principal investigator at Medical University Graz. He is active in several interdisciplinary projects combining single cell signalling with computer science, structural biology, material science and neuro-science. His last research project, ‘ELPHI: A Next Generation Device for Brain Cancer Treatment’, was selected 1000 Ideas Project Program. In 2021, he was promoted as Assoc. Professor for Electrophysiology and Bioelectronic medicine at Medical University of Graz.